General Information
BounceWatch is an independent company data service, not affiliated with Oligogen, Inc.. To contact Oligogen, Inc., visit oligogen.jp.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Oligogen, Inc. compare?
A PDF of Oligogen, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Oligogen, Inc. soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Oligogen, Inc. on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
Japan Market
Biotechnology
About Oligogen, Inc.
Business keywords: biotech startup, stem cell therapies, central nervous system diseases, neural stem cell technologies, OligoGenie, patented technology, pre-clinical phase, drug development, bio-venture, spinal cord injury
Funding Rounds & Investors (1)
View AllOligogen, Inc. Alternatives & Competitors
View All AlternativesNext Generation Therapeutics to successfully address central nervous system, metabolic and respirato...
‘Off-the-Shelf’ Curative Cell Therapies
Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies for the treatment of...
FAQ About Oligogen, Inc.
Source: BounceWatch company record for Oligogen, Inc., https://bouncewatch.com/company/oligogen-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.